The differential expression of PIK3R1, AKR1C3, EGFR, ESR1, PIK3CD, CYP3A4, and CYP19A1 across various cancer types and stages illuminates their potential as biomarkers for cancer progression and prognosis. Here, PIK3CD is linked to cancer.